Table 5.
Reference | PBDE-47 | PBDE-99 | PBDE-100 | PBDE-153 | PCB-153 | Medium | Age | Sex | Country | No. |
---|---|---|---|---|---|---|---|---|---|---|
Present study | 8.1 | 1.4 | 1.1 | 1.4 | 41.7a | Plasma | 48–76 | Female | Canada | 110 |
Schecter et al. 2005b | 12.8 | 3.2 | 2.6 | 3.6 | Blood | 22–91 | Both | United States | 39 | |
Sjödin et al. 2004 | 34 | 11 | 5.9 | 7.3 | 35 | Serum | ? | Both | United States | Pool |
Johnson-Restrepo et al. 2005 | 29.3 | 10.3 | 12.0 | < 1 | 35.2b | Adipose tissue | 18–51 | Both | United States | 52 |
Weiss et al. 2006 | 0.91 | 0.20 | 0.29 | 1.1 | 260 | Serum | 52–81 | Female | Sweden | 53 |
Thomas et al. 2006 | 0.82 | < 0.16 | 0.76 | 1.7 | 41 | Serum | 22–80 | Both | United Kingdom | 154 |
Fängström et al. 2005 | 1.3 | 0.33 | 0.51 | 1.0 | 430 | Serum | ? | Female | Faroes | 57 |
Naert et al. 2006 | 0.88 | 0.47 | 0.72 | 2.40 | 274 | Adipose tissue | 19–84 | Both | Belgium | 53 |
All levels are either GMs or medians and are expressed on a lipid basis (ng/g lipids).
n = 109.
Sum of hexa-chlorinated congeners.